Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats.

The use of injectable biomaterials is of interest in osteoporotic patients to locally restore bone mass in sites at risk of fracture. An injectable bone substitute (IBS1 made of betaTCP/hydroxyapatite as a calcium phosphate substitute and hydroxy-propyl-methyl-cellulose as a polymer carrier) was used in a severely osteopenic rat model obtained by combining orchidectomy (ORX) and disuse (paralysis induced by botulinum toxin - BTX). Fifty-six aged male rats were randomized into three groups: 18 were SHAM operated; 38 were ORX and BTX injected in the right hindlimb; they constituted the OP (osteoporotic) group. One month after ORX-BTX surgery, 20 of these OP rats received a IBS1 injection in the right femur (OP-IBS1 rats). Animals were studied at the time of IBS1 injection 1 month post ORX-BTX (M1), 1 month (M2) and 2 months (M3) after IBS1 injection. Bone mass (BV/TV) and microarchitectural parameters were measured by microCT. BV/TV was decreased after ORX-BTX; ORX and BTX had cumulative effects on bone loss (differences maximized on the right femur). BV/TV (combining the volume of both bone and material in OP-IBS1 rats) was elevated at M1 but decreased at M2. Marked bone formation was found onto the biomaterial granules but bone had a woven texture. A marked increase in the number of nonosteoclastic TRAcP+ cells was found in the implanted area. IBS1 induced new bone formation shortly after implantation but both IBS1 and woven bone were resorbed without inducing lamellar bone. Biomaterial trials must be conducted with long-term implantation periods, in aged osteoporotic animals.

[1]  G. Daculsi,et al.  In vitro evaluation of a new injectable calcium phosphate material. , 1998, Journal of biomedical materials research.

[2]  D. Chappard,et al.  Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. , 1983, Basic and applied histochemistry.

[3]  G. Daculsi,et al.  Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes. , 1999, Journal of biomedical materials research.

[4]  B Kerebel,et al.  Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. , 1989, Journal of biomedical materials research.

[5]  J. Déjou,et al.  The biodegradation mechanism of calcium phosphate biomaterials in bone. , 2002, Journal of biomedical materials research.

[6]  O. Suzuki,et al.  Multinucleated giant cells recruited by implantation of octacalcium phosphate (OCP) in rat bone marrow share ultrastructural characteristics with osteoclasts. , 1997, Journal of electron microscopy.

[7]  I. Hide,et al.  Percutaneous vertebroplasty: history, technique and current perspectives. , 2004, Clinical radiology.

[8]  Michael Jarcho,et al.  Calcium phosphate ceramics as hard tissue prosthetics. , 1981, Clinical orthopaedics and related research.

[9]  G. Daculsi,et al.  Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution. , 1999, Bone.

[10]  D. Vanderschueren,et al.  Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. , 1992, Endocrinology.

[11]  J. Iwamoto,et al.  Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. , 2002, Bone.

[12]  J. Glowacki,et al.  Tissue reactions to particles of bone‐substitute materials in intraosseous and heterotopic sites in rats: discrimination of osteoinduction, osteocompatibility, and inflammation , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[13]  R. Panush,et al.  Clinical medicine: perspectives for the future. , 1993, The American journal of medicine.

[14]  G. Daculsi,et al.  Osteoclastic resorption of biphasic calcium phosphate ceramic in vitro. , 1997, Journal of biomedical materials research.

[15]  S Tamai,et al.  Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. , 1996, Journal of biomedical materials research.

[16]  A. Ravaglioli,et al.  Biomaterials for Orthopedic Surgery in Osteoporotic Bone: A Comparative Study in Osteopenic Rats , 1997, The International journal of artificial organs.

[17]  H. Jinnai,et al.  Surface curvatures of trabecular bone microarchitecture. , 2002, Bone.

[18]  M. Colombier,et al.  Multinucleated giant cells elicited around hydroxyapatite particles implanted in craniotomy defects are not osteoclasts , 1995, The Anatomical record.

[19]  Olivier Gauthier,et al.  In vivo bone regeneration with injectable calcium phosphate biomaterial: a three-dimensional micro-computed tomographic, biomechanical and SEM study. , 2005, Biomaterials.

[20]  J. Currey.  The many adaptations of bone. , 2003, Journal of biomechanics.

[21]  J. Davies,et al.  Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. , 1993, Biomaterials.

[22]  T. Bateman,et al.  Quantification of bone ingrowth into porous block hydroxyapatite in humans. , 1999, Journal of biomedical materials research.

[23]  E. Delain.  Les nouvelles microscopies et leurs perspectives d'avenir , 1999 .

[24]  J. Iwamoto,et al.  Effect of Vitamin K2 on Cortical and Cancellous Bones in Orchidectomized and/or Sciatic Neurectomized Rats , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  M M Chen,et al.  Mechanical loading modifies ovariectomy-induced cancellous bone loss. , 1994, Bone and mineral.

[26]  Christoph Fankhauser,et al.  Augmentation of mechanical properties in osteoporotic vertebral bones – a biomechanical investigation of vertebroplasty efficacy with different bone cements , 2001, European Spine Journal.

[27]  P. Meunier,et al.  Quantitative histological data on disuse osteoporosis , 1974, Calcified Tissue Research.

[28]  G. Daculsi,et al.  Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. , 1998, Biomaterials.

[29]  F. Monchau,et al.  In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. , 2002, Biomolecular engineering.

[30]  N. Passuti,et al.  Long-term bone response to particulate injectable ceramic. , 1998, Journal of biomedical materials research.

[31]  K. Anselme,et al.  Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. , 1998, Journal of biomedical materials research.

[32]  D Chappard,et al.  Synchrotron X-ray microtomography (on a micron scale) provides three-dimensional imaging representation of bone ingrowth in calcium phosphate biomaterials. , 2003, Biomaterials.

[33]  M Vogel,et al.  Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture. , 1992, Bone.

[34]  J. Jansen,et al.  Trabecular bone response to injectable calcium phosphate (Ca-P) cement. , 2002, Journal of biomedical materials research.

[35]  X Demondion,et al.  Percutaneous vertebroplasty: state of the art. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[36]  G. Daculsi,et al.  Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: a comparative study 3 and 8 weeks after implantation in rabbit bone , 2001, Journal of materials science. Materials in medicine.

[37]  G. Daculsi,et al.  In vitro characterization and in vivo properties of a carbonated apatite bone cement. , 2002, Journal of biomedical materials research.

[38]  H. Ohgushi,et al.  Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. , 2000, Journal of biomedical materials research.

[39]  Tomoyuki Saito,et al.  Osteogenic response of hydroxyapatite cement implanted into the femur of rats with experimentally induced osteoporosis. , 2002, Biomaterials.

[40]  D Chappard,et al.  Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. , 2001, Bone.

[41]  T. Uemura,et al.  Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. , 2002, Biomaterials.

[42]  Mechanical properties of the femur after injection of calcium phosphate cement containing arbekacin sulfate and polylactic acid in a rat model of experimental osteoporosis , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[43]  J. Zerwekh,et al.  Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[44]  D. Chappard,et al.  Osteoclastic resorption of Ca-P biomaterials implanted in rabbit bone , 1993, Calcified Tissue International.

[45]  D. Chappard,et al.  Bone Microarchitecture and Bone Fragility in Men: DXA and Histomorphometry in Humans and in the Orchidectomized Rat Model , 2001, Calcified Tissue International.

[46]  D. Chappard,et al.  The early remodeling phases around titanium implants: a histomorphometric assessment of bone quality in a 3- and 6-month study in sheep. , 1999, The International journal of oral & maxillofacial implants.

[47]  E. Seeman.  Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis , 2003, Osteoporosis International.